Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Clinical trial NCT04002180 · COMPLETED

Trial details

NCT number: NCT04002180
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Crohn's Disease

Start date: 2019-07-01
Primary completion: 2026-03-25
Enrollment: 335

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.